Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
Efficacy and Safety of Intensive Insulin Therapy With Insulin Glulisine in Patients With Type 2 Diabetes Inadequately Controlled With Basal Insulin and Oral Glucose-lowering Drugs	Sanofi	Ongoing	Lantus® / Apidra®	4	LANTU_R_05048	National Diabetes Centre (Riyadh)
An observational study to monitor 2- Combination regimen's patterns of oral hypoglycaemic agents in Type 2 diabetic patients in daily clinical practice in Saudi Arabia	Sanofi	Ongoing	2-combination hypoglycaemics	4	DIREG_L_05386	Dr. Erfan & Bagedo General Hospital (Jeddah)
Registry of treatment patterns in patients with metastatic castration-resistant prostate cancer (mCRPC) with progression during or after DOCETAXEL-based regimen	Sanofi	Ongoing	N/A	4	DRIEG_C_05756	King Fahad Medical City (Riyadh), King Fahad Specialist Hospital (Dammam)
An observational Study to evaluate the behaviour of physicians focusing on the preference patterns (reasons to prescribe) of ARB/HCTZ combinations containing high dose (25mg) diuretic for treatment of hypertension in Saudi Arabia	Sanofi	Ongoing	N/A	4	IRBEH_L_05674	King Khalid University Hospital (Riyadh)
Effect of ACS Patients' Education on Adherence to Dual Anti-platelet Therapy (unstable angina + non ST elevation MI + ST elevation MI)	Sanofi	Ongoing	N/A	4	DIREG_L_05229	Dr. Soliman Fakeeh Hospital (Jeddah)
Phase IV, Multicenter, International, Non-comparative, Open Label Study of Efficacy and Safety of Basal Bolus Therapy (Insulin Glargine + Insulin Glulisine) in Patients With T1 Diabetes Previously Uncontrolled on Any Insulin Regimen.	Sanofi	Ongoing	Lantus® + Apidra®	4	LANTU_R_05033	King Khalid University Hospital (Riyadh)
Study of clinical and non clinical predictive factors for achieving glycemic control in people with type 2 diabetes in real clinical practice	Sanofi	Ongoing	Lantus®/Apidra®	4	LANTUR06314	Dr. Erfan & Bagedo General Hospital (Jeddah)
Registry on the use of Lactic acid (Lactacyd) in minor gynecologyical conditions among Middle Eastren women	Sanofi	Ongoing	LACTOSERUM LACTIC ACID	4	LACACL06308	Dr. Erfan & Bagedo General Hospital (Jeddah)
multinational observational study on clinical practices and therapeutic management of mineral and bone disorders in chronic kidney disease 4, 5 & 5D	Sanofi	Ongoing	N/A	4	OBS13593	Saudi center for organ transplantation (Riyadh), King Fahad Hospital (Jeddah)
Clinical Outcomes on ErbB2+ MBC Patients Treated With Lapatinib-Capecitabine After Trastuzumab Progression: Role of Early Versus Late Switch to Lapatinib-Capecitabine (TYCO)	GSK	Ongoing	Lapatinib / Capecitabine	4	113780	King Abdulaziz Medical City NG (Riyadh) , King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Hospital and Oncology Center (Jeddah)